EU patients still face challenges in benefiting from the actions envisaged by the EU directive on cross-border healthcare, according to a new report by the European Court of Auditors. Only a minority of potential patients are aware of their rights to seek medical care abroad. At the same time, the Leggi tutto…
The EC approval is based on the first global CAR-T registration trials, which included patients from eight European countries and demonstrated durable responses and a consistent safety profile in r/r pediatric B-cell ALL and r/rDLBCL Novartis is the only company with an approved CAR-T cell therapy for pediatric r/r B-cell ALL and the Leggi tutto…
The European Court of Auditors is conducting an audit of cross-border healthcare arrangements in the EU. The auditors will examine the European Commission’s monitoring and support for putting the EU legislation on cross-border healthcare access into effect, the results achieved to date for patients, and the effectiveness of the EU Leggi tutto…